NKGen Biotech Korea

엔케이젠바이오텍코리아 · 182400

Health Care Pharmaceuticals · KOSDAQ

Small-cap

Market cap US$192.4M (₩265.5B)

Overview

Company summary coming soon.

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$5.7M

▼ −10.6% YoY

Operating profit · FY2025

−US$1.8M

Loss narrowed

Net income · FY2025

−US$5.3M

Loss narrowed

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2023	FY2024	FY2025
Revenue	US$7.2M(₩9.9B)	US$6.4M(₩8.8B)	US$5.7M(₩7.9B)
Operating profit	−US$48.8M(−₩67.3B)	−US$2.9M(−₩4.1B)	−US$1.8M(−₩2.5B)
Net income	−US$111.2M(−₩153.4B)	−US$26.8M(−₩36.9B)	−US$5.3M(−₩7.3B)

Revenue

Operating profit

Net income

ROE

-103.5%

Debt/Eq

101.5%

Op. margin

-32.2%

Net margin

-93.4%

Rev. YoY

▼ −10.6%

Interactive price history isn't here yet. Would you use it?